_.png)
_.png)
_.png)
.png)
_.png)
_.png)
Report Library
View More
Datamonitor Healthcare CV&Met Disea...
September 25, 2020
Datamonitor Healthcare Oncology: Ce...
September 24, 2020
Datamonitor Healthcare CV&Met: Chem...
September 23, 2020
Datamonitor Healthcare Other: Erect...
September 23, 2020
Datamonitor Healthcare CV&Met: Duch...
September 23, 2020
Datamonitor Healthcare Oncology: Pa...
September 22, 2020
Datamonitor Healthcare Other: Hypog...
September 22, 2020
Datamonitor Healthcare Infectious D...
September 22, 2020
Datamonitor Healthcare Oncology Dis...
September 21, 2020
Datamonitor Healthcare Oncology Dis...
September 21, 2020
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 9/29/20 | Myovant Sciences (MYOV) | Relugolix for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/28/20 | Eiger BioPharmaceuticals (EIGR) | Pegylated Interferon Lambda for COVID-19 | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/25/20 | Johnson & Johnson (JNJ) | JNJ-78436735 for COVID-19 | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/24/20 | Bristol Myers Squibb (BMY) | Opdivo for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/24/20 | Daiichi Sankyo (4568) | Injectafer for Anemia in Heart Failure | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 08/16/19 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 09/29/20 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 09/29/20 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (US) |
| 09/29/20 | Subscribers Only | Subscribers Only | Regulatory - Approval Decision (Europe) |
| 09/29/20 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
